FORM OF SERIES "W" COMMON STOCK PURCHASE WARRANT





 

 EXHIBIT 10.33

 

THIS WARRANT AND THE SECURITIES ISSUABLE UPON EXERCISE HEREOF HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR ANY APPLICABLE STATE LAWS, AND
NO INTEREST THEREIN MAY BE SOLD, DISTRIBUTED, ASSIGNED, OFFERED, PLEDGED OR OTHERWISE TRANSFERRED UNLESS THERE IS AN EFFECTIVE REGISTRATION STATEMENT UNDER SUCH ACT AND APPLICABLE STATE SECURITIES LAWS COVERING ANY SUCH TRANSACTION OR SUCH
TRANSACTION IS EXEMPT FROM THE REGISTRATION REQUIREMENTS OF SUCH ACT AND LAWS.

 

SERIES “W” COMMON STOCK PURCHASE WARRANT

 

Bioject Medical Technologies Inc.

 

        Warrant No. W-1

 

        THIS CERTIFIES that for good and valuable consideration received, Leerink Swann & Company, or registered assigns, is
entitled, upon the terms and subject to the conditions hereinafter set forth, to acquire from Bioject Medical Technologies Inc., an Oregon corporation (the “Corporation”) up to 10,400 fully paid and nonassessable shares of common stock,
without par value, of the Corporation (“Warrant Stock”) at a purchase price per share (the “Exercise Price”) of $13.50.

 

1.    Term of Warrant

 

        Subject to the terms and conditions set forth herein, this Warrant shall be exercisable, in whole or from time to time
part, at any time on or after the date hereof and at or prior to 11:59 p.m., Pacific Standard Time, on June 6, 2006 (the “Expiration Time”).

 

2.    Exercise of Warrant

 

        The purchase rights represented by this Warrant are exercisable by the registered holder hereof, in whole or in part, at
any time and from time to time at or prior to the Expiration Time by the surrender of this Warrant and the Notice of Exercise form attached hereto duly executed to the office of the Corporation at 7620 S.W. Bridgeport Road, Portland, Oregon 97224
(or such other office or agency of the Corporation as it may designate by notice in writing to the registered holder hereof at the address of such holder appearing on the books of the Corporation), and upon payment of the Exercise Price for the
shares thereby purchased (by cash or by check or bank draft payable to the order of the Corporation or by cancellation of indebtedness of the Corporation to the holder hereof, if any, at the time of exercise in an amount equal to the purchase price
of the shares thereby purchased); whereupon the holder of this Warrant shall be entitled to receive from the Corporation a stock certificate in proper form representing the number of shares of Warrant Stock so purchased.

 

3.    Issuance of Shares; No Fractional Shares of Scrip

 

        Certificates for shares purchased hereunder shall be delivered to the holder hereof by the Corporation’s transfer
agent at the Corporation’s expense as promptly as practicable, but in any event within five (5) business days, after the date on which this Warrant shall have been exercised in accordance with the terms hereof. Each certificate so delivered
shall be in such denominations as may be requested by the holder hereof and shall be registered in the name of such holder or, subject to applicable laws, other name as shall be requested by such holder. If, upon exercise of this Warrant, fewer than
all of the shares of Warrant Stock evidenced by this Warrant are purchased prior to the Expiration Time, one or more new warrants substantially in the form of, and on the terms in, this Warrant will be issued for the remaining number of shares of
Warrant Stock not purchased upon exercise of this Warrant. The Corporation hereby represents and warrants that all shares of Warrant Stock which

 

1




 may be issued upon the exercise of this Warrant will, upon such exercise, be duly and validly authorized and issued, fully paid and nonassessable and free from all
taxes, liens and charges in respect of the issuance thereof (other than liens or charges created by or imposed upon the holder of the Warrant Stock). The Corporation agrees that the shares so issued shall be and be deemed to be issued to such holder
as the record owner of such shares as of the close of business on the date on which this Warrant shall have been surrendered for exercise in accordance with the terms hereof. No fractional shares or scrip representing fractional shares shall be
issued upon the exercise of this Warrant. With respect to any fraction of a share called for upon the exercise of this Warrant, an amount equal to such fraction multiplied by the then current price at which each share may be purchased hereunder
shall be paid in cash to the holder of this Warrant.

 

4.    Charges, Taxes and Expenses

 

        Issuance of certificates for shares of Warrant Stock upon the exercise of this Warrant shall be made without charge to
the holder hereof for any issue or transfer tax or other incidental expense in respect of the issuance of such certificate, all of which taxes and expenses shall be paid by the Corporation, and such certificates shall be issued in the name of the
holder of this Warrant or in such name or names as may be directed by the holder of this Warrant; provided, however, that in the event certificates for shares of Warrant Stock are to be issued in a name other than the name of the holder of
this Warrant, this Warrant when surrendered for exercise shall be accompanied by the Assignment Form attached hereto duly executed by the holder hereof.

 

5.    No Rights as Shareholders

 

        This Warrant does not entitle the holder hereof to any voting rights or other rights as a shareholder of the Corporation
prior to the exercise hereof. Notwithstanding the foregoing, if: (i)the Corporation shall declare a dividend (or any other distribution) on its Common Stock; or (ii) the Corporation shall declare a special nonrecurring cash dividend on or a
redemption of its Common Stock; or (iii) the Corporation shall authorize the granting to all holders of the Common Stock rights or warrants to subscribe for or purchase any shares of capital stock of any class or of any rights; or (iv) the approval
of any stockholders of the Corporation shall be required in connection with any reclassification of the Common Stock, any consolidation or merger to which the Corporation is a party, any sale or transfer of all or substantially all of the assets of
the Corporation, or any compulsory share exchange whereby the Common Stock is converted into other securities, cash or property; or (v) the Corporation shall authorize the voluntary dissolution, liquidation or winding up of the affairs of the
Corporation, then the Corporation shall cause to be mailed to each Holder at their last addresses as they shall appear upon the Warrant Register, at least 20 calendar days prior to the applicable record or effective date hereinafter specified, a
notice stating (x) the date on which a record is to be taken for the purpose of such dividend, distribution, redemption, rights or warrants, or if a record is not to be taken, the date as of which the holders of Common Stock of record to be entitled
to such dividend, distributions, redemption, rights or warrants are to be determined or (y) the date on which such reclassification, consolidation, merger, sale, transfer or share exchange is expected to become effective or close, and the date as of
which it is expected that holders of Common Stock of record shall be entitled to exchange their shares of Common Stock for securities, cash or other property deliverable upon such reclassification, consolidation, merger, sale, transfer, share
exchange, dissolution, liquidation or winding up; provided, however, that the failure to mail such notice or any defect therein or in the mailing thereof shall not affect the validity of the corporate action required to be specified in
such notice.

 

6.    Registration Rights

 

        This Warrant is a Series “V” Warrant identified in the Registration Rights Agreement dated as of even date
herewith between the Corporation and the parties listed on the signature pages thereto and is entitled to the benefits thereof. A transferee of this Warrant may become a “Holder” as defined in such agreement upon compliance with the
requirements of such agreement.

 

7.    Exchange and Registry of Warrant

 

        This Warrant is exchangeable, upon the surrender hereof by the registered holder at the above-mentioned office or agency
of the Corporation, for a new Warrant of like tenor and dated as of such exchange. The

 

2




 Corporation shall maintain at the above-mentioned office or agency a registry showing the name and address of the registered holder of this Warrant. This Warrant may
be surrendered for exchange, transfer or exercise, in accordance with its terms, at such office or agency of the Corporation, and the Corporation shall be entitled to rely in all respects, prior to written notice to the contrary, upon such
registry.

 

8.    Loss, Theft, Destruction or Mutilation of Warrant

 

        Upon receipt by the Corporation of evidence reasonably satisfactory to it of the loss, theft, destruction or mutilation
of this Warrant, and in case of loss, theft or destruction of indemnity or security reasonably satisfactory to it, and upon reimbursement to the Corporation of all reasonable expenses incidental thereto, and upon surrender and cancellation of this
Warrant, if mutilated, the Corporation will make and deliver a new Warrant of like tenor and dated as of such cancellation, in lieu of this Warrant.

 

9.    Saturdays, Sundays and Holidays

 

        If the last or appointed day for the taking of any action or the expiration of any right required or granted herein
shall be a Saturday or a Sunday or shall be a legal holiday, then such action may be taken or such right may be exercised on the next succeeding day not a Saturday, Sunday or legal holiday.

 

10.    Merger, Sale of Assets, Etc.

 

        If at any time the Corporation proposes to merge or consolidate with or into any other corporation, effect any
reorganization, or sell or convey all or substantially all of its assets to any other entity, then, as a condition of such reorganization, consolidation, merger, sale or conveyance, the Corporation or its successor, as the case may be, shall enter
into a supplemental agreement to make lawful and adequate provision whereby the holder shall have the right to receive, upon exercise of the Warrant, the kind and amount of equity securities which would have been received upon such reorganization,
consolidation, merger, sale or conveyance by a holder of a number of shares of common stock equal to the number of shares issuable upon exercise of the Warrant immediately prior to such reorganization, consolidation, merger, sale or conveyance. If
the property to be received upon such reorganization, consolidation, merger, sale or conveyance is not equity securities, the Corporation shall give the holder of this Warrant twenty (20) business days prior written notice of the proposed effective
date and a brief statement of the facts of such transaction (including the consideration to be paid), and if this Warrant has not been exercised by or on the effective date of such transaction, it shall terminate.

 

11.    Subdivision, Combination, Reclassification, Conversion, Etc.

 

        If the Corporation at any time shall pay a stock dividend or otherwise make a distribution on shares of its common stock
or on any other class of capital stock payable in shares of its common stock (any such event hereafter referred to as a “common stock distribution”), or by subdivision, combination, reclassification of securities or otherwise, change the
Warrant Stock into the same or a different number of securities of any class or classes, this Warrant shall thereafter entitle the holder to acquire such number and kind of securities as would have been issuable in respect of the Warrant Stock (or
other securities which were subject to the purchase rights under this Warrant immediately prior to such common stock distribution, subdivision, combination, reclassification or other change) as the result of such change if this Warrant had been
exercised in full for cash immediately prior to such change. The Exercise Price hereunder shall be adjusted if and to the extent necessary to reflect such change. If the Warrant Stock or other securities issuable upon exercise hereof are subdivided
or combined into a greater or smaller number of shares of such security, the number of shares issuable hereunder shall be proportionately increased or decreased, as the case may be, and the Exercise Price shall be proportionately reduced or
increased, as the case may be, in both cases according to the ratio which the total number of shares of such security to be outstanding immediately after such event bears to the total number of shares of such security outstanding immediately prior
to such event. The Corporation shall give the holder prompt written notice of any change in the type of securities issuable hereunder, any adjustment of the Exercise Price for the securities issuable hereunder, and any increase or decrease in the
number of shares issuable hereunder.

 

3




 

 12.    Transferability; Compliance with Securities Laws

 


		         (a)    This Warrant may not be transferred or assigned in
whole or in part without compliance with all applicable federal and state securities laws by the transferor and transferee (including the delivery of investment representation letters and legal opinions reasonably satisfactory to the Corporation, if
requested by the Corporation). Subject such restrictions, prior to the Expiration Time, this Warrant and all rights hereunder are transferable by the holder hereof, in whole or in part, at the office or agency of the Corporation referred to in
Section 1 hereof. Any such transfer shall be made in person or by the holder’s duly authorized attorney, upon surrender of this Warrant together with the Assignment Form attached hereto properly endorsed.




 


		         (b)    The Holder of this Warrant, by acceptance hereof,
acknowledges that this Warrant and the Warrant Stock issuable upon exercise hereof are being acquired solely for the holder’s own account and not as a nominee for any other party, and for investment, and that the holder will not offer, sell or
otherwise dispose of this Warrant or any shares of Warrant Stock to be issued upon exercise hereof except under circumstances that will not result in a violation of the Securities Act of 1933, as amended, or any state securities laws. Upon exercise
of this Warrant, the holder shall, if requested by the Corporation, confirm in writing, in a form satisfactory to the Corporation, that the shares of Warrant Stock so purchased are being acquired solely for holder’s own account and not as a
nominee for any other party, for investment, and not with a view toward distribution or resale except under circumstances that will not result in a violation of the Securities Act of 1933, as amended, or any state securities laws.




 


		         (c)    The Warrant Stock has not been registered under
the Securities Act of 1933, as amended, and this Warrant may not be exercised except by (i) the original purchaser of this Warrant from the Corporation or (ii) an “accredited investor” as defined in Rule 501(a) under the Securities Act of
1933, as amended. If then required by applicable securities laws, each certificate representing the Warrant Stock or other securities issued in respect of the Warrant Stock upon any stock split, stock dividend, recapitalization, merger,
consolidation or similar event, shall be stamped or otherwise imprinted with a legend substantially in the following form (in addition to any legend required under applicable securities laws):




 

        THE SECURITIES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER UNITED STATES FEDERAL OR STATE SECURITIES LAWS AND MAY
NOT BE OFFERED FOR SALE, SOLD OR OTHERWISE TRANSFERRED OR ASSIGNED FOR VALUE, DIRECTLY OR INDIRECTLY, NOR MAY THE SECURITIES BE TRANSFERRED ON THE BOOKS OF THE CORPORATION, WITHOUT REGISTRATION OF SUCH SECURITIES UNDER ALL APPLICABLE UNITED STATES
FEDERAL OR STATE SECURITIES LAWS OR COMPLIANCE WITH AN APPLICABLE EXEMPTION THEREFROM.

 

13.    Representations and Warranties

 

        The Corporation hereby represents and warrants to the holder hereof that:

 


		         (a)    during the period this Warrant is outstanding, the
Corporation will reserve from its authorized and unissued common stock a sufficient number of shares to provide for the issuance of Warrant Stock upon the exercise of this Warrant;




 


		         (b)    the issuance of this Warrant shall constitute full
authority to the Corporation’s officers who are charged with the duty of executing stock certificates to execute and issue the necessary certificates for the shares of Warrant Stock issuable upon exercise of this Warrant;




 


		         (c)    the Corporation has all requisite legal and
corporate power to execute and deliver this Warrant, to sell and issue the Warrant Stock hereunder, to issue the common stock issuable upon exercise of the Warrant Stock and to carry out and perform its obligations under the terms of this
Warrant;




 


		         (d)    all corporate action on the part of the
Corporation, its directors and shareholders necessary for the authorization, execution, delivery and performance of this Warrant by the Corporation, the authorization,




 

4





		  sale, issuance and delivery of the Warrant Stock, the grant of registration rights as provided herein and the performance of
the Corporation’s obligations hereunder has been taken;




 


		         (e)    the Warrant Stock, when issued in compliance with
the provisions of this Warrant, will be validly issued, fully paid and nonassessable, and free of all taxes, liens or encumbrances with respect to the issue thereof, and will be issued in compliance with all applicable federal and state securities
laws; and




 


		         (f)    the issuance of the Warrant Stock will not be
subject to any preemptive rights, rights of first refusal or similar rights.




 

14.    Corporation

 

        The Corporation will not, by amendment of its Articles of Incorporation or through any reorganization, recapitalization,
transfer of assets, consolidation, merger, dissolution, issue or sale of securities or any other action, avoid or seek to avoid the observance or performance of any of the terms to be observed or performed hereunder by the Corporation, but will at
all times in good faith assist in the carrying out of all the provisions of this Warrant and in the taking of all such action as may be necessary or appropriate in order to protect the rights of the holder of the Warrant against
impairment.

 

15.    Governing Law

 

        This Warrant shall be governed by and construed in accordance with the laws of the State of Oregon.

 

        IN WITNESS WHEREOF, the Corporation has caused this Warrant to be executed by its duly authorized officers.

 

Dated: June 6, 2001

 


		 BIOJECT MEDICAL TECHNOLOGIES INC.




 


		 





		 By: 






		 Name: James C. O’Shea





		 Title: Chairman & Chief Executive Officer




 

5




 

 NOTICE OF EXERCISE

 

To: Bioject Medical Technologies Inc.

 

        (1)    The undersigned hereby elects to purchase        
          shares of common stock of Bioject Medical Technologies Inc. pursuant to the terms of the attached Warrant, and tenders herewith payment of the purchase price in full, together with all
applicable transfer taxes payable by the undersigned pursuant to the Warrant , if any.

 

        (2)    In exercising this Warrant, the undersigned hereby confirms and acknowledges that the shares
of common stock to be issued upon exercise hereof are being acquired solely for the account of the undersigned and not as a nominee for any other party, and for investment, and that the undersigned will not offer, sell or otherwise dispose of any
such shares of common stock except under circumstances that will not result in a violation of the Securities Act of 1933, as amended, or any state securities laws.

 

        (3)    Please issue a certificate or certificates representing said shares of common stock in the
name of the undersigned or in such other name as is specified below:

 

 


		 





(Name)

 

 


		 





(Address)

 

        (4)    The undersigned represents that (a) he, she or it is the original purchaser from the
Corporation of the attached Warrant or an “accredited investor” within the meaning of Rule 501(a) under the Securities Act of 1933, as amended and (b) the aforesaid shares of common stock are being acquired for the account of the
undersigned for investment and not with a view to, or for resale in connection with, the distribution thereof and that the undersigned has no present intention of distributing or reselling such shares except under circumstances that will not result
in a violation of the Securities Act of 1933, as amended, or any state securities laws.

 


	  




(Date)

		  




(Signature)

	


 

6




 

 ASSIGNMENT FORM

 

(To assign the foregoing Warrant, execute this form and supply required information. Do not use this form to purchase shares.)

 

        FOR VALUE RECEIVED, the undersigned registered owner of this Warrant hereby sells, assigns and transfers unto the
Assignee named below all of the rights of the undersigned under the within Warrant, with respect to the number of shares of common stock of Bioject Medical Technologies Inc. set forth below:

 


	Name of Assignee
	  	Address
	  	No. of Shares

	                       
                                   	  	                       
                                   	  	                       
                                   
	 	    		    	
	 	    		    	


 

and does hereby irrevocably constitute and appoint Attorney                  
                                to make such transfer on the books of Bioject Medical
Technologies Inc., maintained for the purpose, with full power of substitution in the premises.

 

        The undersigned also represents that, by assignment hereof, the Assignee acknowledges that this Warrant and the shares
of stock to be issued upon exercise hereof are being acquired for investment and that the Assignee will not offer, sell or otherwise dispose of this Warrant or any shares of stock to be issued upon exercise hereof except under circumstances which
will not result in a violation of the Securities Act of 1933, as amended, or any state securities laws. Further, the Assignee shall, if requested by the Corporation, confirm in writing, in a form satisfactory to the Corporation, that the shares of
stock so purchased are being acquired for investment and not with a view toward distribution or resale.

 

 


		 Dated: 





 

 


		 Holder’s Signature: 





 

 


		 Holder’s Address:




 


		  





 

 


		  





 

Guaranteed Signature:

 

        NOTE: The signature to this Assignment Form must correspond with the name as it appears on the face of the Warrant,
without alteration or enlargement or any change whatever, and must be guaranteed by a bank or trust company. Officers of corporations and those action in a fiduciary or other representative capacity should file proper evidence of authority to assign
the foregoing Warrant.

 

7